[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352789-105":59,"doc-detail-352789-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lack-of-de-intensification-models-for-female-head-and-neck-cancer-patients-with-favorable-prognosis","Lack of De-Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis","","Study addresses how gender is treated as a prognostic factor in head and neck cancer, with focus on HPV-associated oropharyngeal squamous cell carcinoma where de-escalation is being tested. Nationwide German Cancer Registry data (2002–2017; n=212,920) are used to assess sex-specific survival across primary tumor sites, followed by a local cohort of 462 OPSCC patients (2005–2018; follow-up to 2024). Sex prognosis is compared with HPV status, alcohol, and smoking.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lack-of-de-intensification-models-for-female-head-and-neck-cancer-patients-with-favorable-prognosis/352789/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lack-of-de-intensification-models-for-female-head-and-neck-cancer-patients-with-favorable-prognosis/352789.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does the study investigate gender in head and neck cancer?","Question",{"text":112,"@type":113},"The prognostic relevance of gender is often neglected in head and neck cancer, even though HPV-associated OPSCC has a more favorable prognosis and de-escalation strategies are being tested. The study clarifies whether gender should receive greater attention.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What datasets and patient groups were used?",{"text":117,"@type":113},"The study used German Cancer Registry data for 212,920 newly diagnosed patients from 2002 to 2017. It also analyzed a local OPSCC dataset of 462 patients diagnosed from 2005 to 2018 and followed up until 2024.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the nationwide and local analyses show about survival by sex?",{"text":121,"@type":113},"Nationwide, women had better survival across studied primary tumor sites, with the largest mean survival difference in OPSCC (1.3 years). In the local OPSCC dataset, men with HPV-positive disease did not show a better prognosis than women, and the female sex effect could be attenuated in patients with high tobacco use.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352789,1790472068,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nLack of De-Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis  \nJ. M. Vahl1  | J. Hahn1 | A. von Witzleben1 | S. M. Schroeder1  | C. Idel2 | B. Wollenberg3 | T. K. Hoffmann1 | S. Laban1  \n1Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Ulm, Ulm, Germany | 2Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Schleswig-Holstein, Lübeck, Germany | 3Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center of the Technical University Munich, Munich, Germany  \nCorrespondence: J. M. Vahl ([julius.vahl@uniklinik-ulm.de](julius.vahl@uniklinik-ulm.de))  \nReceived: 7 June 2025 | Revised: 26 October 2025 | Accepted: 4 March 2026  \nKeywords: alcohol | head and neck tumor | human papillomavirus | sex | smoking  \nABSTRACT  \nPurpose: The prognostic relevance of gender in head and neck cancer is often neglected. In contrast, the more favorable prognosis of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is well recognized, and de-escalation strategies are increasingly being tested in clinical trials. In this study, we focused on the prognostic significance of gender to clarify whether it should be given more attention.  \nPatients and Methods: We requested data on patients with newly diagnosed head and neck cancer between 2002 and 2017 from the German Center of Cancer Registry (n = 212,920). First, we focused on sex-specific survival according to primary tumor site ina nationwide context. Second, we examined a local dataset of 462 OPSCC patients, diagnosed at the University Hospitals of Ulm and Lübeck between 2005 and 2018 and followed up until 2024. Here we compared the prognostic value of sex with HPV status, alcohol consumption, and smoking habits (these parameters were not available at national level) .  \nResults: In the nationwide analysis, women showed better survival in all head and neck primary tumor sites studied. The mean survival difference was greatest in patients with OPSCC (1.3 years; p \u003C 0.0001), followed by patients with nasopharyngeal carcinoma (1 year; p\u003C 0.0001). In the subgroup of patients younger than the median age (62.8years), women lived on mean 1.2 times longer than men (p \u003C 0.0001). Besides, in the local dataset, men with HPV-positive OPSCC did not have a better prognosis than women, even when HPV-negative (p = 0.426) . However, the prognostic effect of female sex may be attenuated in patients with high tobacco use; in this scenario, no sex-related difference in survival was found (p = 0.56) .  \nConclusion: Sex-specific differences in survival, especially in OPSCC and nasopharyngeal cancers, suggest the implementation of gender-sensitive oncology regarding prevention, treatment, and aftercare.  \n1 | Introduction  \nWe recently performed a nationwide analysis of 212,920 head and neck cancer patients in Germany between 2002 and 2017 [1, 2] . Hereby we examined tumor incidence, stage, gender distribution, travel distance, age-, site-, and diagnosis-time-specific survival. In particular, we confirmed gender as an independent prognostic factor and showed that the median overall survival of women exceeds that of men by an incredible 2 years [1] . This  \nwas a key finding which we would like to shed more light on in this work.  \nAlthough gender-specific oncology is an emerging field of medicine involving pharmacologists and physicians, it has received little attention in treatment guidelines or clinical trials. However, gender differences in cancer development (including non-sexspecific cancers), treatment response, and side effects have been studied. Men are more likely to be affected and have a poorer  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©","cbCainLbGk76E913","https://ap.wps.com/l/cbCainLbGk76E913","pdf",975040,"English","# Abstract\n## Purpose\n## Patients and Methods\n## Results\n## Conclusion\n# Introduction\n## Background on gender-specific oncology\n## Rationale and related evidence","[{\"question\":\"Why does the study investigate gender in head and neck cancer?\",\"answer\":\"The prognostic relevance of gender is often neglected in head and neck cancer, even though HPV-associated OPSCC has a more favorable prognosis and de-escalation strategies are being tested. The study clarifies whether gender should receive greater attention.\"},{\"question\":\"What datasets and patient groups were used?\",\"answer\":\"The study used German Cancer Registry data for 212,920 newly diagnosed patients from 2002 to 2017. It also analyzed a local OPSCC dataset of 462 patients diagnosed from 2005 to 2018 and followed up until 2024.\"},{\"question\":\"What did the nationwide and local analyses show about survival by sex?\",\"answer\":\"Nationwide, women had better survival across studied primary tumor sites, with the largest mean survival difference in OPSCC (1.3 years). In the local OPSCC dataset, men with HPV-positive disease did not show a better prognosis than women, and the female sex effect could be attenuated in patients with high tobacco use.\"}]","Lack of De-Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis | PDF",1790101381,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e86dd6e00fd8e43e728f832993392394.webp",983,1291,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e9665b7378bfe768f0728400d54e8d4a.webp",982,1290,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebeddbb59cc57f0de134d70e278d6623.webp",981,1289,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3dfa068c36cc9373edc2a5054fe43009.webp",980,1287]